Pfizer Asks FDA To Authorize Experimental COVID-19 Antiviral Pill, Paxlovid

Pfizer announced on Tuesday it is asking federal regulators to authorize its experimental antiviral COVID-19 pill and the Biden administration plans to purchase 10 million doses, according to a source familiar with the plans.